SkyePharma Stock Price, News & Analysis (LON:SKP)

GBX 444 0.00 (0.00 %)
(As of 01/19/2018 04:00 PM ET)
Previous CloseGBX 444
Today's RangeN/A
52-Week RangeGBX 249.25 - GBX 486.25
Average Volume177,955 shs
Market Capitalization£470.25 million
P/E Ratio1,776.00
Dividend YieldN/A

About SkyePharma (LON:SKP)

SkyePharma logoSkyepharma Ltd, formerly Skyepharma PLC, is a drug delivery company engaged in the development of oral and inhalation products. The Company operates as an independent developer of complex pharmaceutical products for global markets. Its principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies. It operates through the segment of development and supply of pharmaceutical products. It is also involved in the supply of products to its marketing partners, as in the case for flutiform and over seven oral products manufactured in its Lyon Facility. It operates primarily for respiratory applications. Its inhalation products include Relvar Ellipta/Breo Ellipta, Anoro Ellipta and Incruse Ellipta. Its oral products include RAYOS/LODOTRA, Requip Once-a-day, Xatral/Uroxatral, Madopar DR/Prolopa, Sular, ZYFLO CR, Paxil CR, Diclofenacratiopharm Uno, Triglide and Coruno.

Receive SKP News and Ratings via Email

Sign-up to receive the latest news and ratings for SKP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio1776
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSGBX 0.25
Net IncomeN/A
Net Margins32.70%
Return on Equity79.41%
Return on Assets35.64%


Outstanding Shares105,910,000

SkyePharma (LON:SKP) Frequently Asked Questions

What is SkyePharma's stock symbol?

SkyePharma trades on the London Stock Exchange (LON) under the ticker symbol "SKP."

Who are some of SkyePharma's key competitors?

How do I buy SkyePharma stock?

Shares of SkyePharma and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is SkyePharma's stock price today?

One share of SkyePharma stock can currently be purchased for approximately GBX 444.

How big of a company is SkyePharma?

SkyePharma has a market capitalization of £470.25 million.

How can I contact SkyePharma?

SkyePharma's mailing address is 46-48 Grosvenor Gardens, LONDON, SW1W 0EB, United Kingdom. The company can be reached via phone at +44-20-78810524.

MarketBeat Community Rating for SkyePharma (SKP)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  169 (Vote Underperform)
Total Votes:  233
MarketBeat's community ratings are surveys of what our community members think about SkyePharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

SkyePharma (LON:SKP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A

SkyePharma (LON:SKP) Consensus Price Target History

Price Target History for SkyePharma (LON:SKP)

SkyePharma (LON:SKP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
2/17/2016Stifel NicolausReiterated RatingBuyGBX 460View Rating Details
1/28/2016N+1 SingerReiterated RatingCorporateView Rating Details
1/22/2016FinnCapReiterated RatingBuyView Rating Details
(Data available from 1/20/2016 forward)


Earnings History for SkyePharma (LON:SKP)

No earnings announcements for this company have been tracked by


SkyePharma (LON:SKP) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for SkyePharma (LON:SKP)

No dividend announcements for this company have been tracked by

Insider Trades

SkyePharma (LON SKP) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for SkyePharma (LON:SKP)

SkyePharma (LON SKP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/29/2016Derodra,AndrewInsiderBuy32GBX 473£151.36
3/31/2016Derodra,AndrewInsiderBuy33GBX 449£148.17
1/2/2016Grant,PeterInsiderBuy46GBX 327£150.42
11/30/2015Derodra,AndrewInsiderBuy46GBX 327£150.42
11/4/2015Grant,PeterInsiderBuy47GBX 322£151.34
10/30/2015Derodra,AndrewInsiderBuy47GBX 322£151.34
10/5/2015Grant,PeterInsiderBuy42GBX 354£148.68
9/4/2015Derodra,AndrewInsiderBuy48GBX 312£149.76
8/4/2015Grant,PeterInsiderBuy54GBX 279£150.66
7/3/2015Derodra,AndrewInsiderBuy55GBX 273£150.15
(Data available from 1/1/2013 forward)


SkyePharma (LON SKP) News Headlines


SEC Filings

SkyePharma (LON:SKP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.


Financials are not available for this stock.


SkyePharma (LON SKP) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.